The effect of counseling on self-esteem and self-efficacy women with Breast cancer
Not Applicable
Completed
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT2017062834802N1
- Lead Sponsor
- Vice chancellornfor research, Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
women 30-50 years old; chemotherapy treatment; literacy reading and writing.
Exclusion criteria: do not participate in a maximum of one sessions and desire to exit from the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-esteem. Timepoint: Before the intervention?immediately after intervention?one month after intervention completion. Method of measurement: Self-esteem inventory.
- Secondary Outcome Measures
Name Time Method Self-efficacy. Timepoint: Before the intervention?immediately after intervention?one month after intervention completion. Method of measurement: Cancer behavior inventory.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie acceptance and commitment therapy's impact on self-esteem in breast cancer patients?
How does acceptance and commitment therapy compare to cognitive-behavioral therapy in improving self-efficacy among breast cancer survivors?
Are there specific biomarkers that correlate with enhanced psychological outcomes following acceptance and commitment therapy in malignant breast neoplasm cases?
What adverse events are associated with acceptance and commitment therapy interventions in oncology settings and how are they managed?
What combination approaches integrate acceptance and commitment therapy with standard breast cancer treatments to optimize patient well-being?